Stichting OLVG — Clinical Trial Site

86 Registered trials

36 Currently recruiting

Organisation

Stichting OLVG

Location

Amsterdam, Netherlands

Identifier

ORG-100029947

Address

Oosterpark 9, 1091 AC, Netherlands

Departments

#1703: Cardiology
#2901:Cardiology
#3724: Cardiology
2619:Cardiology
3724: Cardiology
Anaesthesia
Anesthesiology
Cardiology
Cardiology Research
Department of Gastroenterology & hepatology
Department of Surgery
Gastroenterology
Gynecology and obstetrics
Hematologie Oncologie
Hematology
Hematology-Oncology
Intensive Care
Internal Disease
Internal Medicine
Internal medicine / Oncology
Interne geneeskunde
Klinische Research Cardiologie
MDL
Medical Oncology
Medical Oncology and Hematology
N/A
NA
Neurologie
Neurology
Obstrics & Gynecology
Oncology
Ophthalmology
Orthopedic surgery
orthopedics
Psychiatry
Pulmonology
Secretariaat cardiologie research N3.59
Surgery
Surgery HPB and colorectal

Clinical trials at this site (86)

Search interface

A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects with Crohn's Disease who Comple… Ended

2023-504951-29-00 Chron's Disease 5 2017-07-27
Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer (monarchE) Ended

2023-509671-17-00 Breast Cancer 5 2017-07-12
A Phase III double-blind placebo-controlled Randomised Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients Ended

2022-502324-48-00 Patients with resected colon carcinoma 5 2014-08-05
Biomarker discovery randomized phase IIb trial with carboplatin-cyclophosphamide versus paclitaxel with or without atezolizumaB as first-lin… Ended

2024-516202-39-00 Metastatic breast cancer 4 2013-10-10
PUMP-IT RCT: Hepatic arterial infusion PUMP chemotherapy combined with systemic therapy versus systemic therapy alone as Induction Therapy f… Halted

2023-506194-35-00 Colorectal liver metastases 5 2024-11-21
A Study to Understand the ability and safety of GDC-8264 in Preventing kidney Injury and Major Adverse Kidney Events following Heart Surgery Ended

2024-513125-23-00 Patients with moderate to high risk for cardiac surgery 4 2025-02-28
A large global trial to evaluate the efficacy and safety of milvexian in reducing recurrent cardiovascular events in patients after a heart … Ended

2022-501418-69-00 Acute Coronary Syndrome 5 2023-11-21
A study to test asundexian for preventing a stroke caused by a clot in participants after an acute ischemic stroke or after a high-risk tran… Ended

2023-503793-20-00 Prevention of ischemic stroke in patients post acute no 5 2023-01-18
A multicenter, randomized, open-label, blinded endpoint evaluation, phase 3 study comparing the effect of abelacimab relative to apixaban on… Ended

2023-509569-19-00 venous thromboembolism (VTE) 10 2022-08-10
A study to learn how well the treatment combination of finerenone and empagliflozin works and how safe it is compared to each treatment alon… Ended

2023-506981-30-00 Chronic kidney disease in type 2 diabetes mellitus 4 2022-05-25
A Phase 3, randomized, double-blind, placebo-controlled, multicenter study of IV FDY-5301 in patients with a myocardial infarction (STEMI) Ended

2024-514372-40-00 Anterior ST-Elevation Myocardial Infarction 5 2022-04-12
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke Ended

2023-503673-38-00 Adults at high risk of cardiovascular events without pr 5 2019-05-24
GIVE trial (Gazyvaro In combination with VEnetoclax in Elderly CLL) Ended

2024-511048-22-00 Chronic lymphocytic leukemia 4 2016-10-27
HD21 Ended

2024-518022-33-00 Advanced Stage of Hodgkin Lymphoma 5 2016-07-15